References
- 1. Hegazy WAH. Diclofenac inhibits virulence of Proteus mirabilis isolated from diabetic foot ulcer. Afr J Microbiol. Res. 2016;10:733-43.
- 2. Schaffer JN, Pearson MM. Proteus mirabilis and urinary tract infections. J Microbiol Spect. 2015;3(5).
- 3. Brzozowska E, Pyra A, Pawlik K, Janik M, Górska S., Urbańska N. Hydrolytic activity determination of tail tubular Protein A of Klebsiella pneumoniae bacteriophages towards saccharide substrates. J Sci Rep. 2017;7(1):18048.
- 4. Brotzki CR, Mergenhagen KA,, Bulman ZP, Tsuji BT, Berenson ChS. Native valve Proteus mirabilis endocarditis: successful treatment of a rare entity formulated by in vitro synergy antibiotic testing. BMJ Case Rep. 2016;bcr2016215956.
- 5. Wang Y, Zhang S, Yu J, Zhang H, Yuan Z, Sun Y, Song H. An outbreak of Proteus mirabilis food poisoning associated with eating stewed pork balls in brown sauce, Beijing. J Food Control. 2010; 21(3):302-5.
- 6. Cohen-Nahum K, Saidel-Odes L, Riesenberg K, Schlaeffer F, Borer A. Urinary tract infections caused by multi-drug resistant Proteus mirabilis: risk factors and clinical outcomes. J Infection. 2010;38(1): 41-6.
- 7. NakanoR, Nakano A, Abe M, Inoue M, Okamoto R. Regional outbreak of CTX-M-2 β-lactamase-producing Proteus mirabilis in Japan. J Med Microbiol. 2012;61(12):1727-35.
- 8. Nagano N, Shibata N, Saitou Y, Nagano Y, Arakawa Y. Nosocomial outbreak of infections by Proteus mirabilis that produce Extended – spectrum CTX-M-2 type β-lactamase. J Clin Microbiol. 2003;41(12): 5530-6.
- 9. Jain S, Gaind R, Kothari C, Sehgal R, Shamweel A, Thukral SS, et al. VEB-1 extended-spectrum β-lactamase-producing multidrug-resistant Proteus mirabilis sepsis outbreak in a neonatal intensive care unit in India: clinical and diagnostic implications. JMM Case Rep. 2016;3(4): e005056. doi: 10.1099/jmmcr.0.005056.10.1099/jmmcr.0.005056
- 10. Rogan D, Babiuk LA. Novel vaccines from biotechnology. J Rev Sci Tech. 2005;24(1):159-74.
- 11. Kim D, Heajun JH, Lim L, Kyung MW, Hyun MR, Shik G, et al. N-acetyl cysteine Prevents LPS induced pro-inflammatory cytokines and MMP2 Production in Gingival fibroblast. Arch Pharm Res. 2007; 30(10):1283-92.
- 12. Darweesh MF. Molecular characterization of ESBL gene in Citrobacter spp. and antibacterial activity of omega-3 against resistant isolates. Curr Issues Phar Med Sci. 2017;30(3):156-61.
- 13. Christensen D, Korsholm KS, Andersen P, Agger EM. Cationic liposomes as vaccine adjuvants. J Expert Review Vacc. 2011;10(4): 513-21.
- 14. Alavi M, Karimi N, Safaei M. Application of various types of liposomes in drug delivery systems. J Adv Pharm Bull. 2017;7(1):3.
- 15. Naser HH, Salih SM, Al-Shaibani AB. Protective humoral immunity induced by lipopolysaccharide incorporated liposome in mice against shigellaflexneri infection. J Al-Nahrain Univ. 2013; 16(3):205-13.
- 16. Miernikiewicz P, Kłopot A, Soluch R, Szkuta P, Kęska W, Hodyra-Stefaniak K, et al. T4 phage tail adhesin gp12 counteracts LPS-induced inflammation in vivo. J. Frontiers Microbiol. 2016;7:1112.
- 17. Dharmadhikari SM, Peshwe AS. Molecular level studies on multiple antibiotic and serum resistance in UTI pathogens. Indian J Biotechnol. 2009;8:40-5.
- 18. Silipo A, Lanzetta R, Amoresano A, Parrilli M, Moliaro A. Ammonium hydroxide hydrolysis: a valuable support in the MALDITOF mass spectrometry analysis of lipid A fatty acid distribution. J Lipid Res. 2002;43:2188-95.
- 19. Chandan V, Fraser AD. Simple extraction of Campylobacter lipopolysaccharide and protein antigens and production of their antibodie in egg yolk. Inter L Food Microbiol. 1994;22:189-200.
- 20. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Determination of sugars and related substances. J Anal Chem. 1956;28: 350-35621
- 21. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Ann Biochem. 1976;72:248-254.
- 22. Xianguo H, Ursula M. Antifungal compound from Solanum nigrescens. J Ethanopharm. 1994;43:173-7.
- 23. Reed LJ, Muench HA. simple method of estimation fifty percent end points. Am J Hyg. 1938;27:493-8.
- 24. Alui Y, Nwude N. Determination of the medin lethal dose (LD 50) In: Velerenary Pharmacology and Toxicology Experiments. J. Baraka Press Zaria; 1982:104-22.
- 25. Rittig MG, Kaufmann A, Robins A, Shaw B, Sprenger H, Gemsa D, et al. Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytes. J Leuk Biol. 2003;74(6):1045-55.
- 26. Malik SN. Study the effect of polysaccharide extracted from Proteus merabilis in protect UTI in animal lab. Master thesis - Baghdad Uni. College of science. (In Arabic) 2006.
- 27. Lan F, Yue X, Ren G, Wang Y, Xia T. Serum toll-like receptors are potential biomarkers of radiation pneumonia in locally advanced NSCLC. Inter J Clin Exper Path. 2014;7(11):8087.
- 28. Ghosh C, Bishayi B. Characterization of toll-like receptor-4 (TLR-4) in the spleen and thymus of Swiss Albino mice and its modulation in experimental endotoxemia. J Immunol Res. 2015.
- 29. MacRae S, Herman C, Stulting RD, Lippman R, Whipple D, Cohen E, Phillips D. Corneal ulcer and adverse reaction rates in premarket contact lens studies. AmJ Ophthal. 1991;111(4):457-465.
- 30. Watanabe S, Kumazawa Y, Inoue J. Liposomal lipopolysaccharide initiates TRIF-dependent signaling pathway independent of CD14. PLoS One. 2013;8(4), e60078.
- 31. Heldwein KA, Fenton MJ. The role of Toll-like receptors in immunity against mycobacterial infection. Microb Infect. 2002;4(9):937-44.
- 32. Stils Jr, Harold F. Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants. J. ILAR46. 2005;3:280-293.
- 33. Karananou P, Fleva A, Tramma D, Alataki A, Pavlitou-Tsiontsi A, Emporiadou-Peticopoulou M, Papadopoulou-Alataki E. Altered expression of TLR2 and TLR4 on peripheral CD14+ blood monocytes in children with urinary tract infection. BioMed Res Inter. 2016.
- 34. Landmann R, Knopf HP, Link S, Sansano S, Schumann R, Zimmerli W. Human monocyte CD14 is upregulated by lipopolysaccharide. J Infect Immun. 1996;64(5):1762-9.
- 35. Stewart EC, McIntosh TJ, Poxton, IR.The biological activity of a liposomal complete core lipopolysaccharide vaccine. J Endotoxin Res. 2002;8(1):39-46.
- 36. O’Hagan TD, Friedland LR, Hanon E, Didierlaurent AM. Towards an evidence based approach for the development of adjuvanted vaccines. Curr Opin Immunol. 2017;47:93-102.
- 37. Abid AJ, Alwan SJ. Role of T regulatory cells with valvular heart disease. Res J Pharm Biol Chem Sci. 2016;7(3):1473-8.
- 38. Khadhim MM, Al-Hajjiah NN, Shaheed OM. Detection of the CD64 on neutrophils and CD69 on lymphocytes by flowcytometry as a marker for early diagnosis of neonatal sepsis. Sepsis, 2015;8:9.